These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6800827)
1. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test. Wietholtz H; Voegelin M; Arnaud MJ; Bircher J; Preisig R Eur J Clin Pharmacol; 1981; 21(1):53-9. PubMed ID: 6800827 [TBL] [Abstract][Full Text] [Related]
2. CO2 breath tests using 14C-caffeine, 14C-methacetin and 14C-phenacetin for assessing postnatal development of monooxygenase activities in rats and marmosets. Krüger N; Helge H; Neubert D Dev Pharmacol Ther; 1991; 16(3):164-75. PubMed ID: 1914790 [TBL] [Abstract][Full Text] [Related]
3. Detection of carcinogen-induced stimulation of cytochrome P-448-associated enzymes by 14CO2 breath analysis studies using dimethylaminoazobenzene. Hepner GW; Piken EP Gastroenterology; 1979 Feb; 76(2):267-71. PubMed ID: 103777 [TBL] [Abstract][Full Text] [Related]
4. Caffeine demethylation measured by breath analysis in experimental liver injury in the rat. Schaad HJ; Renner EL; Wietholtz H; Arnaud MJ; Preisig R J Hepatol; 1995 Jan; 22(1):82-7. PubMed ID: 7751592 [TBL] [Abstract][Full Text] [Related]
5. Radioisomers of scoparone (6,7-dimethoxycoumarin) as a tool for in vivo differentiation of various hepatic monooxygenase inducers in mice using the breath test technique. Legrum W; Kling L; Funke E J Pharmacol Exp Ther; 1984 Mar; 228(3):769-73. PubMed ID: 6423809 [TBL] [Abstract][Full Text] [Related]
6. A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs. Thornhill DP; Steffen C; Netter KJ Eur J Drug Metab Pharmacokinet; 1984; 9(2):161-8. PubMed ID: 6430705 [TBL] [Abstract][Full Text] [Related]
7. The in vivo measurement of expired 14CO2 derived from the N-demethylation of aminopyrine as a reflection of the in vitro hepatic cytochrome P-450 drug-metabolism activity in rats. Kotake AN; Schreider BD; Latts JR Drug Metab Dispos; 1982; 10(3):251-8. PubMed ID: 6125358 [TBL] [Abstract][Full Text] [Related]
8. Caffeine: a model compound for measuring liver function. Renner E; Wietholtz H; Huguenin P; Arnaud MJ; Preisig R Hepatology; 1984; 4(1):38-46. PubMed ID: 6420303 [TBL] [Abstract][Full Text] [Related]
9. Chlorinated paraffins: effect of some microsomal enzyme inducers and inhibitors on the degradation of 1-14C-chlorododecanes to 14CO2 in mice. Darnerud PO Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):110-5. PubMed ID: 6437140 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test. Bastien MC; Villeneuve JP Can J Physiol Pharmacol; 1998; 76(7-8):756-63. PubMed ID: 10030456 [TBL] [Abstract][Full Text] [Related]
11. Acceleration of 7-[methoxy-14C]coumarin-derived carbon dioxide exhalation by cobalt pretreatment in mice. Legrum W; Frahseck J J Pharmacol Exp Ther; 1982 Jun; 221(3):790-4. PubMed ID: 6806466 [TBL] [Abstract][Full Text] [Related]
12. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats. Black KA; Virayotha V; Tephly TR Hepatology; 1984; 4(5):871-6. PubMed ID: 6434391 [TBL] [Abstract][Full Text] [Related]
13. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Abraham K; Geusau A; Tosun Y; Helge H; Bauer S; Brockmöller J Clin Pharmacol Ther; 2002 Aug; 72(2):163-74. PubMed ID: 12189363 [TBL] [Abstract][Full Text] [Related]
14. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152 [TBL] [Abstract][Full Text] [Related]
15. The antipyrine breath test in the rat: a pharmacokinetic model. Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242 [TBL] [Abstract][Full Text] [Related]
16. Hybrid information provided by the 14C-aminopyrine breath test. Studies with 14C-monomethylaminoantipyrine in the guinea pig. Roots I; Nigam S; Gramatzki S; Heinemeyer G; Hildebrandt AG Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):175-8. PubMed ID: 6775236 [TBL] [Abstract][Full Text] [Related]
17. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. Watkins PB; Murray SA; Winkelman LG; Heuman DM; Wrighton SA; Guzelian PS J Clin Invest; 1989 Feb; 83(2):688-97. PubMed ID: 2913056 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride. Schoeller DA; Kotake AN; Lambert GH; Krager PS; Baker AL Hepatology; 1985; 5(2):276-81. PubMed ID: 3920135 [TBL] [Abstract][Full Text] [Related]
19. Aminopyrine demethylation measured by breath analysis in cirrhosis. Bircher J; Küpfer A; Gikalov I; Preisig R Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720 [TBL] [Abstract][Full Text] [Related]
20. Rate of drug metabolism in man measured by 14CO2-breath analysis. Platzer R; Galeazzi RL; Karlaganis G; Bircher J Eur J Clin Pharmacol; 1978 Dec; 14(4):293-9. PubMed ID: 153232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]